Skip to main content

Federal Rescheduling in 2026: From Speculation to Reality for Cannabis Employers

Green and gray split light bulb silhouette representing federal cannabis rescheduling and regulatory change. Federal cannabis rescheduling creates new considerations for employers navigating tax treatment, regulatory compliance and workforce planning.

For years, federal cannabis rescheduling was a hypothetical talking point. That changed in 2026.

On April 28, 2026, the Department of Justice moved marijuana contained in FDA approved drug products, and marijuana sold under a state issued medical marijuana license, from Schedule I to Schedule III of the Controlled Substances Act. That order now faces its own legal challenges in federal court, separate from the broader rescheduling process below.

Recreational and other non-medical cannabis remain Schedule I for now. A separate, expedited DEA hearing on broader rescheduling ran from June 29 to July 15, 2026, before DEA Chief Administrative Law Judge Derek Julius. His recommendation was still pending as of this writing, with a final decision from the DEA Administrator potentially following in 2027.

For cannabis employers, one effect has already arrived. State licensed medical cannabis operators are generally no longer subject to IRC Section 280E, the tax rule that has long disallowed deductions for wages, benefits, and other ordinary expenses. Recreational operators remain subject to Section 280E unless and until broader rescheduling is finalized.

Rescheduling does not legalize recreational cannabis federally, create interstate commerce, or resolve federal banking restrictions.

Employers should:

  • Confirm with tax counsel whether current operations qualify for 280E relief
  • Model workforce and compensation budgets under both current and possible future tax treatment
  • Avoid assuming that full federal legalization or banking access is imminent

The path forward remains incremental rather than sudden. Employers who track developments closely and plan for multiple outcomes will be best positioned as this process continues into 2027.

Excelerator® helps cannabis employers translate regulatory and tax developments into practical workforce and compensation strategy.

×
Stay Informed

When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.

Workplace Violence Prevention: An Emerging Priorit...
The War for Cannabis Talent: Why Compliance and Op...